Adelphi Values | PROVE exhibiting at ISPOR Glasgow
Adelphi Values | PROVE will be leading a podium presentation entitled ‘Differences in vaccine pricing between high‑income and low‑income markets’.
Covering 7 different disease areas, the presentation will give an overview of market access for vaccines in lower income countries, discuss the reasons behind the huge price difference and the contributing factors, and also the role of organisations such as PAHO and GAVI in addressing market access. The presentation will be taking place at 16:45-17:45 on Tuesday 7th November in room Forth (Armadillo).
We will also have six scientific poster presentations, as well as a wide range of presentations from the wider Adelphi team, on display across the 3 days. The diverse research covers a range of therapy areas, healthcare products and services including immunotherapies, vaccines, orphan drugs, medical devices, maternal screening/treatments, cost-effectiveness assessments, patient preferences, real-world treatment experiences and quality of life. A full list of the presentations can be found here.
Adelphi Values | PROVE will also be exhibiting alongside the Adelphi Values Patient Centered Outcomes practice and sister company Adelphi Real World. Members of our Real World, Values and Outcomes team will be on hand to discuss the presentations in more detail or answer any questions you may have. Come and visit us at booth 301 – we look forward to seeing you!
The 20th Annual European Congress of ISPOR (the International Society of Pharmacoeconomics and Outcomes Research) takes place from 4th-8th November 2017 in Glasgow, Scotland, and is recognised as the leading scientific and educational organisation for outcomes research in healthcare decisions, hosting many of the foremost experts from around the world.
To set up a meeting with us at ISPOR, or if you would like further information on our presentations or on any of our broader healthcare value consultancy solutions, please contact us or alternatively email info@adelphivalues.com.